MedCap AB Statistics
Total Valuation
MedCap AB has a market cap or net worth of SEK 6.22 billion. The enterprise value is 6.22 billion.
Market Cap | 6.22B |
Enterprise Value | 6.22B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MedCap AB has 14.98 million shares outstanding. The number of shares has decreased by -0.21% in one year.
Current Share Class | n/a |
Shares Outstanding | 14.98M |
Shares Change (YoY) | -0.21% |
Shares Change (QoQ) | -0.64% |
Owned by Insiders (%) | 4.22% |
Owned by Institutions (%) | 57.68% |
Float | 11.38M |
Valuation Ratios
The trailing PE ratio is 29.69 and the forward PE ratio is 26.98.
PE Ratio | 29.69 |
Forward PE | 26.98 |
PS Ratio | 3.44 |
PB Ratio | 4.83 |
P/TBV Ratio | 9.19 |
P/FCF Ratio | 19.56 |
P/OCF Ratio | 17.29 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.16, with an EV/FCF ratio of 19.54.
EV / Earnings | 29.98 |
EV / Sales | 3.44 |
EV / EBITDA | 18.16 |
EV / EBIT | 25.82 |
EV / FCF | 19.54 |
Financial Position
The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.28.
Current Ratio | 2.77 |
Quick Ratio | 1.88 |
Debt / Equity | 0.28 |
Debt / EBITDA | 1.05 |
Debt / FCF | 1.12 |
Interest Coverage | 13.02 |
Financial Efficiency
Return on equity (ROE) is 18.08% and return on invested capital (ROIC) is 10.26%.
Return on Equity (ROE) | 18.08% |
Return on Assets (ROA) | 8.24% |
Return on Invested Capital (ROIC) | 10.26% |
Return on Capital Employed (ROCE) | 14.51% |
Revenue Per Employee | 3.05M |
Profits Per Employee | 350,338 |
Employee Count | 592 |
Asset Turnover | 0.99 |
Inventory Turnover | 2.75 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.54% in the last 52 weeks. The beta is 0.56, so MedCap AB's price volatility has been lower than the market average.
Beta (5Y) | 0.56 |
52-Week Price Change | -1.54% |
50-Day Moving Average | 374.37 |
200-Day Moving Average | 487.40 |
Relative Strength Index (RSI) | 69.54 |
Average Volume (20 Days) | 32,772 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedCap AB had revenue of SEK 1.81 billion and earned 207.40 million in profits. Earnings per share was 14.00.
Revenue | 1.81B |
Gross Profit | 1.06B |
Operating Income | 240.90M |
Pretax Income | 261.60M |
Net Income | 207.40M |
EBITDA | 304.90M |
EBIT | 240.90M |
Earnings Per Share (EPS) | 14.00 |
Balance Sheet
The company has 370.10 million in cash and 358.00 million in debt, giving a net cash position of 12.10 million or 0.81 per share.
Cash & Cash Equivalents | 370.10M |
Total Debt | 358.00M |
Net Cash | 12.10M |
Net Cash Per Share | 0.81 |
Equity (Book Value) | 1.29B |
Book Value Per Share | 85.62 |
Working Capital | 585.90M |
Cash Flow
In the last 12 months, operating cash flow was 360.00 million and capital expenditures -41.70 million, giving a free cash flow of 318.30 million.
Operating Cash Flow | 360.00M |
Capital Expenditures | -41.70M |
Free Cash Flow | 318.30M |
FCF Per Share | 21.25 |
Margins
Gross margin is 58.52%, with operating and profit margins of 13.33% and 11.48%.
Gross Margin | 58.52% |
Operating Margin | 13.33% |
Pretax Margin | 14.47% |
Profit Margin | 11.48% |
EBITDA Margin | 16.87% |
EBIT Margin | 13.33% |
FCF Margin | 17.61% |
Dividends & Yields
MedCap AB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.21% |
Shareholder Yield | 0.21% |
Earnings Yield | 3.33% |
FCF Yield | 5.11% |
Stock Splits
The last stock split was on September 27, 2016. It was a reverse split with a ratio of 0.1.
Last Split Date | Sep 27, 2016 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
MedCap AB has an Altman Z-Score of 8.29.
Altman Z-Score | 8.29 |
Piotroski F-Score | n/a |